This announcement is a separate document:
迈威生物：迈威生物自愿披露关于9MW2821联合特瑞普利单抗一线治疗尿路上皮癌纳入突破性治疗品种公示名单的公告
Maiwei Biotech: Maiwei Biotech voluntarily disclosed the announcement that 9MW2821 combined with treprimab was included in the public list of breakthrough treatment varieties for first-line treatment of urothelial cancer
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.